Caremark, FCPA and Corporate Governance

The landmark decision — In re Caremark International Inc. Derivative Litigation — has even more implications in today’s aggressive FCPA enforcement environment….As an example, within one week of a corporation’s disclosure of suspected FCPA violations requiring an internal investigation, over twenty-five separate shareholder suits were filed. For companies weighing the need for compliance, this is another risk to the company and its directors. The collateral consequences to companies from FCPA violations are multiplying and director liability is yet another twist.

Read more: Caremark, FCPA and Corporate Governance — White Collar Defense & Compliance